Background/Aims: Stress-induced cell senescence, which contributes to cell cycle arrest and is independent of age, plays an important role in chronic kidney disease (CKD) progression. DcR2, as a senescent marker, exclusively expressed in senescent tubular epithelia. The objective of this study was to examine whether urinary DcR2 (uDcR2) could be a potential biomarker for tubulointerstitial fibrosis (TIF) in patients with immunoglobulin A nephropathy (IgAN). Methods: This study included 210 IgAN patients and 80 healthy volunteers, with uDcR2 levels measured using enzyme-linked immunosorbent assay. We examined the relationship among uDcR2/Cr levels, renal function, and pathological parameters, using regression analysis to identify risk factors for TIF and the area under the curve (AUC) approach to predict TIF. Renal DcR2 expression was quantified by immunohistochemistry. Co-expression of DcR2 with fibrotic markers (α-smooth muscle actin [α-SMA], collagen III) was analyzed by confocal microscopy. Results: Levels of uDcR2/Cr were significantly higher in IgAN patients and in those with more severe TIF, compared with healthy controls. Serum DcR2 levels were similar across groups. The proportion of IgAN patients with stages 1-2 CKD and T0 was highest among those with uDcR2/Cr < 130 ng/g. In contrast, the majority of those with uDcR2/Cr > 201 ng/g had stages 4-5 CKD and T2. Levels of uDcR2/Cr were positively associated with urinary albumin to creatinine ratio (ACR), urinary N-acetyl-β-D-glucosaminidase (uNAG)/Cr, and TIF scores and negatively associated with estimated glomerular filtration rate (eGFR). uDcR2/Cr, uNAG, ACR, and eGFR were independent predictors for TIF, with AUC of 0.907 for uDcR2/Cr. This AUC value was higher than that observed for eGFR, uNAG/Cr, or ACR. The sensitivity and specificity of uDcR2/Cr in predicting TIF were 87.0 and 80.5%, respectively. Moreover, uDcR2/Cr levels were positively associated with the percentage of renal DcR2 expression. Renal DcR2 colocalized with α-SMA and collagen III in the kidneys of IgAN patients. Conclusions: Levels of uDcR2/Cr were closely associated with the severity of TIF and renal function parameters. uDcR2/Cr represents a potential biomarker for predicting TIF in IgAN patients.
Introduction
Immunoglobulin A nephropathy (IgAN) is the most common primary glomerulonephritis in young adults [1, 2] . About 20-40% of patients with IgAN experience deterioration of renal function, progressing to end-stage renal disease within 20 years [3] . Evidence suggests that tubulointerstitial injury is an independent risk factor for the progression of IgAN and prominently affects patient prognosis [4] . During clinical practice, tubulointerstitial injury is assessed predominantly by pathological examination of renal biopsy specimens. However, renal biopsy is an invasive procedure, and repetitive biopsy can be difficult. Traditional renal function markers, including proteinuric amount and estimated glomerular filtration rate (eGFR), typically estimate the extent of injury to the glomeruli but not to the tubulointerstitium. Therefore, it is imperative to identify a noninvasive biomarker capable of assessing the severity of tubulointerstitial injury [5] [6] [7] [8] [9] [10] .
Stress-induced cell senescence denotes the process of an age-independent cell cycle arrest, induced by various pathological stimuli. Cellular senescence can result in irreversible tissue damage and organ dysfunction [11, 12] . Senescent cells can secrete various senescence-associated secretory phenotypes, including proinflammatory factors and chemokines, which accelerate the progression of tissue damage and play a significant role in diabetes, cardiovascular disease, and chronic kidney disease (CKD) [11, 12] . CKD has been considered as a clinical model of premature senescence [11] . Previously, we found that tubular epithelia expressed senescent markers such as p16, p21, and senescence-associated-β-galactosidase, which were closely associated with the severity of tubulointerstitial injury and poorer renal function among young patients with IgAN [13] .These findings indicate that cellular senescence plays an important role in the pathogenesis of tubulointerstitial injury in patients with IgAN. Uncovering a clinically useful biomarker to evaluate the severity of tubulointerstitial injury based on the extent of cellular senescence may be a promising approach.
DcR2, a decoy receptor for tumor necrosis factor-related apoptosis-inducing ligand, is a marker of senescence [5, 6, 14] . Previous studies found that DcR2 was highly expressed in senescent tumor cells and was associated with the degree of tumor differentiation [5, 6] . DcR2 is also expressed in activated senescent hepatic stellate cell, which protects senescent cell from cytotoxicity, eventually resulting in liver fibrosis [6] . Our laboratory previously found that DcR2 was exclusively expressed in renal tubular epithelia and co-expressed with senescent markers in patients with diabetic nephropathy, and the extracellular portion of DcR2 was detectable in urine [15, 16] . In this study, we aimed to measure the ratio of urinary DcR2 to urinary creatinine (uDcR2/Cr) and renal DcR2, to evaluate the relationship between DcR2 expression and the severity of tubulointerstitial injury in IgAN patients. We hypothesized that uDcR2/Cr could be a biomarker for predicting the severity of tubulointerstitial injury in IgAN patients.
Pathological Classification and Histological Scoring of IgAN
Two pathologists assessed the sections according to the Oxford classification of IgAN [18] , based on the following criteria: T (tubular atrophy/interstitial fibrosis ≤25%, T0; 25-50%, T1; > 50%, T2); E (endocapillary hypercellularity); S (segmental sclerosis); C (crescents); hyaline changes in arteries; and M (mesangial hypertrophy).
Measurement of DcR2 Levels in Blood and Urine with Enzyme-Linked Immunosorbent Assay
We collected blood and urine from patients with IgAN, 1 day before renal biopsy. In the control group, blood and urine were collected from samples obtained during health checkups. Supernatant harvested from collected samples after centrifugation at 1,000 g for 15 min were stored at -80 ° C. Specimens were diluted 5 times. DcR2 levels were measured with a sandwich enzyme-linked immunosorbent assay kit (Abcam), according to the manufacturer's instructions. uDcR2 levels were calibrated to urinary Cr to account for sample concentration [19] .
Measurement of Urinary N-acetyl-β-D-glucosaminidase and Other Parameters
Urinary N-acetyl-β-D-glucosaminidase (uNAG) level was measured with a spectrophotometer calibrated to urinary Cr level, as described in our previous report (Chen et al. [16] ). Biochemical parameters were measured with an automatic chemistry analyzer (Beckman). eGFR was calculated using the CKD -Epidemiology Collaboration equation [20] .
Immunohistochemical Staining for Renal DcR2 Expression
Renal biopsy specimens, at a thickness of 2.5 μm, were treated with a mouse DcR2 monoclonal antibody (Abcam) as the primary antibody (1: 400). Two pathologists blinded to the study results independently assessed the specimens [21] and calculated the percentages of tubular epithelia with positive DcR2 staining in 10 randomly selected highpower fields.
Immunofluorescence Double Staining
DcR2 were co-stained with α-smooth muscle actin (α-SMA) and collagen III (Abcam). The primary antibody for DcR2 was bound by a Cy3-labeled secondary antibody (Abcam), while α-SMA and collagen III were bound by a FITC-labeled secondary antibody (Abcam). Images were obtained by a laser scanning confocal microscope (Leica). Percentages of tubular epithelia with positive staining for DcR2 and α-SMA were calculated. 
Statistical Analyses
Statistical analyses were conducted using SPSS version 20.0. Normally distributed data were described as and analyzed using one-way analysis of variance. Nonnormally distributed data were described as medians with interquartile ranges in parentheses and analyzed using the Kruskal-Wallis test. Count data were described as frequency (with percentage) and analyzed using the chi-square test. Analyses of correlations between uDcR2 levels and renal function markers were performed using Pearson's correlation or Spearman's rank-order correlation. We used logistic regression to identify risk factors for tubulointerstitial was used to evaluate the sensitivity and specificity of uDcR2 as a marker for predicting TIF. p < 0.05 was considered significant. 
Results

Clinical Characteristics of Healthy Controls and Patients with IgAN
Clinical features of 210 subjects with IgAN and those of 80 healthy controls are shown in Table 1 . Compared with the healthy controls, IgAN patients had higher systolic blood pressure, serum uric acid (UA), Cr, and urinary albumin to Cr ratio (ACR) levels but lower serum albumin, hemoglobin, and eGFR levels (all p < 0.05). There was no difference in age, gender, body mass index, or diastolic blood pressure between the 2 groups. IgAN patients were further classified into 3 subgroups: T0 (n = 120), T1 (n = 71), and T2 (n = 19), based on the T scores of the Oxford classification of IgAN. We found that with higher T scores, IgAN patients also had higher systolic blood pressure, serum UA, Cr, and urinary ACR levels, but lower hemoglobin and eGFR.
uDcR2/Cr and uNAG/Cr and Serum DcR2 Levels in Patients with IgAN uDcR2/Cr and uNAG/Cr levels were significantly higher in patients with IgAN, compared with those in healthy controls. Among those with higher T scores, uDcR2/Cr and uNAG/Cr levels were also higher among patients with IgAN; however, there was no significant difference in serum DcR2 levels between healthy controls and IgAN patients ( Table 2) . 
Distribution of IgAN Patients with Different CKD Stages and T Scores According to the Tertile of uDcR2/Cr Levels
Patients with IgAN were classified into 3 subgroups based on their uDcR2/Cr level: < 130, 130-210, and > 210 ng/g. With higher CKD stage, IgAN patients had higher uDcR2/Cr levels. uDcR2/Cr levels similarly increased in association with T scores (Fig. 1 ).
Correlations between uDcR2/Cr Levels and Clinical and Histopathological Parameters
We observed positive associations between uDcR2/Cr levels and serum UA, urinary ACR, and uNAG/Cr, and pathological findings including the severity of tubular atrophy/interstitial fibrosis, interstitial inflammation, glomerulosclerosis, and segmental glomerular hypercellularity/adhesion. A negative correlation was found between uDcR2/Cr levels and eGFR (Table 3) .
Logistic Regression Analysis to Identify Risk Factors for TIF
We analyzed the clinical and pathological features of IgAN patients to identify determinants for TIF > 25% using logistic regression analyses (Table 4 ). Univariate analysis showed that higher serum UA, eGFR, urinary ACR, uDcR2/Cr, and uNAG/Cr were associated with TIF > 25%, while higher baseline eGFR was associated with decreased risk for TIF. Multivariate logistic regression analysis showed that ACR (OR 2.11, p = 0.007), eGFR (OR 0.97, p = 0.019), uDcR2/Cr (OR 3.23, p < 0.001), and uNAG (OR 1.55, p = 0.032) levels were independent predictors for TIF > 25% among IgAN patients. Based on the abovementioned risk factors for TIF (eGFR as X1, ACR as X2, uDcR2/Cr as X3, and uNAG/Cr as X4), we constructed the regression model as follows: Logit (P) = -5.953 -1.361*eGFR + 1.404*ACR + 1.674*uDcR2/Cr + 1.201*uNAG.
Using this regression formula, the possibility of having TIF > 25% among IgAN patients could be inferred using known eGFR, urinary ACR, uDcR2/Cr, and uNAG values. 
ROC Curve Analysis of uDcR2/Cr and uNAG/Cr for Predicting TIF in IgAN Patients
IgAN patients were further classified into 2 groups based on the presence or absence of TIF (presence vs. absence, 120 vs. 90), and we applied the ROC curves to estimate the sensitivity and specificity of using uDcR/Cr to predict TIF. We found that area under the curve was 0.907 for uDcR/Cr, which is significantly higher than that for traditional TIF marker NAG (area under the curve = 0.746; Fig. 2) . The best cutoff for diagnosing TIF was 156.82 ng/g, with sensitivity and specificity of 87 and 80.5%, respectively. 
Tubular DcR2 Expression and Its Correlation with uDcR2/Cr in IgAN Patients
Immunohistochemistry staining showed that DcR2 was exclusively expressed in renal tubular epithelial cells (RTECs) but not glomeruli (Fig. 3A) . Compared with the healthy controls, IgAN patients had significantly higher renal DcR2 expression ( Fig. 3B ). In addition, Fig. 4 ).
Co-expression of DcR2 and Fibrotic Markers in Renal Tissue
The expressions of α-SMA and collagen III increased with higher TIF scores in IgAN patients. Immunofluorescence double staining showed that DcR2 was mainly expressed in areas that stained positive for α-SMA and collagen III (Fig. 5A, D) . We also found that higher TIF scores were associated with increasing percentages of doubly positive-staining cells (Fig. 5B, C) . From these findings, we inferred that DcR2-positive senescent epithelia may contribute to TIF and worsen the outcomes of IgAN patients. Discussion TIF is an important outcome predictor among patients with IgAN [22] . Urine biomarkers including NAG, kidney injury molecule-1, and neutrophil gelatinase-associated lipocalin have been utilized for the evaluation of tubulointerstitial injury [14, [23] [24] [25] , but these biomarkers cannot be used to determine the extent of tubular proliferation and repair. Prior studies suggested that stress-induced senescence of tubular epithelia was pathophysiologically important in the course of IgAN. Senescent cells may cause damage to healthy cells in adjacent areas, leading to local inflammation and fibrosis through the process of senescence-associated secretory phenotypes (including proinflammatory factors and chemokines). In addition, senescent cells can also suppress cellular proliferation and regeneration, leading to irreversible injury and a slowed repair process. In line with these data, we tried to identify biomarkers reflective of tubular repair and to determine whether there was a correlation with the severity of tubulointerstitial injury among patients with IgAN. Traditional markers of cellular senescence, such as p16 and p21, are mainly expressed in tubular cell nuclei and plasma, although these markers are not secreted and not detectable in the urine [26, 27] . In contrast, the extracellular portion of the senescence marker DcR2 can be cleaved and then detected in biologic fluid. Based on this assumption, we measured uDcR2/Cr levels among groups of IgAN patients and healthy volunteers and found that uDcR2/Cr levels were significantly higher among IgAN patients compared with healthy controls. Similarly, uDcR2/Cr levels increased with higher tubulointerstitial injury scores. Our findings suggest that uDcR2/Cr could be a potential biomarker for tubulointerstitial injury among IgAN patients.
DcR2 is a 42-kDa transmembrane protein and can be filtered freely by glomeruli, a property that may impact the uDcR2/Cr level. We found that there was no difference in serum DcR2 levels between IgAN patients and healthy controls, while uDcR2 levels were significantly higher in IgAN patients, compared with healthy controls. These findings indicate that urine uDcR2/Cr level can be a surrogate for the severity of kidney injury, similar to results obtained previously in our study of patients with diabetic nephropathy. In conclusion, uDcR2/ Cr might be a novel biomarker for TIF in patients with CKD. To uncover the source of uDcR2, we performed immunohistochemistry staining of renal tissues. The results showed that tubular epithelia but not glomerular cells expressed DcR2. It is likely that uDcR2/Cr comes directly from DcR2-expressing senescent tubular cells, and DcR2 is a potential marker for evaluating TIF.
Using multivariate logistic regression, we found that uDcR2/Cr was an independent predictor of TIF. Previously, Machiguchi and colleagues discovered that uNAG/Cr could be a useful marker for predicting the progression of IgAN; levels correlated closely with both clinical and histological findings [28] . In another study, the sensitivity and specificity of uNAG/Cr for the diagnosis of Lee's grade III IgAN were 82.4 and 60.5%, respectively [29] . Based on our findings, DcR2 could be a superior biomarker for IgAN. We further showed that DcR2 co-colocalized with fibrotic markers. These findings suggest that DcR2-positive senescent cells can increase the production of extracellular matrix and collagen III, resulting in renal fibrosis. uDcR2/Cr could be a noninvasive biomarker for evaluating the severity of TIF among patients with IgAN, with significantly higher sensitivity and specificity than offered by traditional markers such as NAG. However, the current study is still limited in several ways. It is a cross-sectional single-center study, so prospective studies with a larger sample size are needed to confirm the utility of uDcR2/Cr for diagnosis and evaluation of prognosis in patients with IgAN. In conclusion, uDcR2/Cr is a potential biomarker for accurately evaluating the severity of tubulointerstitial injury in IgAN. 
